ACQUISITION OF CORE ONCOLOGY'S PROSTATE BRACHYTHERAPY CUSTOMER BASE (Tables)

6 Months Ended

Jun. 30, 2012

Asset Acquisition Disclosure [Abstract]

Schedule of finite-lived intangible assets acquired as part of business combination

	Amount		Estimated Life
Inventory	$	253
Developed technology equipment		325	7 years
Intangibles
Customer relationships		7,898	7 years
Non-compete agreements		669	5 years
Developed technology		192	1.5 years
		8,759	6.7 years
Total estimated cost of assets acquired	$	9,337